![Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-01609/article_deploy/html/images/pharmaceuticals-16-01609-g001.png)
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
![Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK499554/bin/fm.s5f1.jpg)
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
![Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40265-023-01897-2/MediaObjects/40265_2023_1897_Fig3_HTML.png)
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
![Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
![Role of ICS/LABA combination therapy in (a) asthma and (b) COPD [8].... | Download Scientific Diagram Role of ICS/LABA combination therapy in (a) asthma and (b) COPD [8].... | Download Scientific Diagram](https://www.researchgate.net/publication/262074515/figure/fig1/AS:216417816322049@1428609436157/Role-of-ICS-LABA-combination-therapy-in-a-asthma-and-b-COPD-8-Asthma-guidelines.png)
Role of ICS/LABA combination therapy in (a) asthma and (b) COPD [8].... | Download Scientific Diagram
![Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología](https://static.elsevier.es/multimedia/03002896/0000005800000001/v1_202201130549/S0300289621003471/v1_202201130549/en/main.assets/gr3.jpeg)
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología
![Optimizing asthma management: Role of long-acting muscarinic antagonists - Journal of Allergy and Clinical Immunology Optimizing asthma management: Role of long-acting muscarinic antagonists - Journal of Allergy and Clinical Immunology](https://www.jacionline.org/cms/asset/6fd3b623-9d75-48e0-99d6-295c91fb025f/gr1.jpg)
Optimizing asthma management: Role of long-acting muscarinic antagonists - Journal of Allergy and Clinical Immunology
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/4-Figure1-1.png)
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig3_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia – HarDoctor News, il Blog di Carlo Cottone Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia – HarDoctor News, il Blog di Carlo Cottone](https://hardoctor.files.wordpress.com/2022/05/terapia-inalatoria-triplice-vs-doppia.jpg)
Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia – HarDoctor News, il Blog di Carlo Cottone
![Positioning of dual (LABA/LAMA) versus mono-LABD in the individualized... | Download Scientific Diagram Positioning of dual (LABA/LAMA) versus mono-LABD in the individualized... | Download Scientific Diagram](https://www.researchgate.net/publication/369471332/figure/fig1/AS:11431281129653563@1679590970873/Positioning-of-dual-LABA-LAMA-versus-mono-LABD-in-the-individualized-management-of-COPD.png)
Positioning of dual (LABA/LAMA) versus mono-LABD in the individualized... | Download Scientific Diagram
![Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40265-023-01897-2/MediaObjects/40265_2023_1897_Fig2_HTML.png)
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
![Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00347-6/MediaObjects/41533_2023_347_Fig1_HTML.png)